top of page
Subscribe
Latest
All News
Reports
Events
Directory
Contact
More
Use tab to navigate through the menu items.
Headlines
Log In
Ratioing the resected gastric volume to the number of fired staplers predicts weight loss
Ratioing the resected gastric volume (RGV) to the number of staplers fired (SF) could be used to predict midterm weight loss, according...
GLP-1 drugs reduce surgery complications in patients with diabetes
People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of...
Over half of Americans are unaware that bariatric surgery can improve fertility
Ratioing the resected gastric volume to the number of fired staplers predicts weight loss
Reduced complication-related costs and enhanced patient recovery using the Ezisurg Endostapler
Research
Journal Watch 15/1/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
AUDACITY Trial: Low rate of serious adverse events supports favourable safety profile of the Allurion Balloon
Allurion Technologies has revealed topline results - from the AUDACITY Food & Drug Administration (FDA) pivotal trial evaluating the...
ReShape Lifesciences provides merger update with Vyome Therapeutics
ReShape Lifesciences and Vyome Therapeutics have provided an update on the definitive merger agreement under which ReShape and Vyome will...
Over half of Americans are unaware that bariatric surgery can improve fertility
A new national survey by Orlando Health has found 56% of Americans are unaware that bariatric surgery improves fertility. Infertility...
Journal Watch 8/1/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Biomea Fusion announces first data on icovamenib-semaglutide combination study
Biomea Fusion has announced ‘compelling’ results from in vivo studies of icovamenib in combination with semaglutide. Icovamenib is an...
MBX Biosciences announces positive phase 1 topline results for MBX 1416 for the treatment of PBH
MBX Biosciences has announced positive results from its Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical...
Turkey bans swallowable gastric balloons
The Ministry of Health in Turkey has announced a ban on swallowable gastric balloons after experts raised concerns about the risks...
Variant Bio and Novo Nordisk sign multi-year research partnership to discover novel targets for metabolic disease
Variant Bio has announced a multi-year research collaboration with Novo Nordisk to discover novel targets for the treatment of metabolic...
GLP-1 drugs reduce surgery complications in patients with diabetes
People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of...
Younger adults face rising gastric cancer risk
A global study has revealed a disturbing rise in early-onset gastric cancer, a disease once predominantly affecting older adults but now...
New MRI technique identifies heart disease risk from fat composition
Researchers from the University of Virginia's (UVA) Department of Biomedical Engineering are seeking to use magnetic resonance imaging...
Industry
ReShape Lifesciences provides merger update with Vyome Therapeutics
Variant Bio and Novo Nordisk sign multi-year research partnership to discover novel targets for metabolic disease
Rhythm gains expanded indication for IMCIVREE (setmelanotide) for patients as young as 2 years old
Zepbound (tirzepatide) is the first and only FDA approved prescription medicine for moderate-to-severe OSA in adults with obesity
All caught up?
See all news
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Browse directory
Events
(See all)
9 April 2025
Iberian Bariatric Surgery Course
View details
8 September 2025
Sixth IBC Oxford University World Congress 2025
View details
20 February 2025
9th IFSO-APC and 22nd OSSICON meeting
View details
11 May 2025
32nd European Congress on Obesity
View details
14 May 2025
13th Congress of IFSO-EC
View details
12 December 2024
3rd IFSO MENAC & 20th ESBS 2024 Meeting
View details
9 September 2025
XXVIII IFSO World Congress
View details
16 June 2025
16th BOMSS Annual Scientific Meeting
View details
Tweets
bottom of page